Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitis

BACKGROUND: Currently accepted therapies for ragweed allergy in North America consist of pharmacotherapy and subcutaneous allergen immunotherapy injections to treat symptoms. Allergen immunotherapy not only reduces symptoms and the need for pharmacotherapy but has also been shown to have disease-mod...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Allergy Asthma Clin Immunol
Hoofdauteurs: Kim, Harold, Waserman, Susan, Hébert, Jacques, Blaiss, Michael, Nelson, Harold, Creticos, Peter, Kaur, Amarjot, Maloney, Jennifer, Li, Ziliang, Nolte, Hendrik
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2014
Onderwerpen:
Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4363352/
https://ncbi.nlm.nih.gov/pubmed/25788949
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1710-1492-10-55
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items